Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 2 (2005), Issue 6 (June)

1. Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21).
   Leuk Res, 29(7): 855-8. [Abstract] [Full-text]
2. Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.
   Leuk Res, 29(7): 849-53. [Abstract] [Full-text]
3. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
   J Clin Invest, 115(6): 1503-21. [Abstract] [Full-text]
4. Adjuvant docetaxel for node-positive breast cancer.
   N Engl J Med, 352(22): 2302-13. [Abstract] [Full-text]
5. Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
   Clin Cancer Res, 11(11): 4225-33. [Abstract] [Full-text]
6. Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001.
   Eur J Clin Microbiol Infect Dis, 24(5): 329-33. [Abstract] [Full-text]
7. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
   Blood, 105(12): 4573-5. [Abstract] [Full-text]
8. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
   Blood, 105(12): 4664-70. [Abstract] [Full-text]
9. Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
   Blood, 105(12): 4576-82. [Abstract] [Full-text]
10. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
    Blood, 105(12): 4878-84. [Abstract] [Full-text]
11. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
    Blood, 105(12): 4792-9. [Abstract] [Full-text]
12. Occupational exposure to benzene in South Korea.
    Chem Biol Interact, 153: 65-74. [Abstract] [Full-text]
13. Exposure to benzene and non-Hodgkin lymphoma, an epidemiologic overview and an ongoing case-control study in Shanghai.
    Chem Biol Interact, 153: 33-41. [Abstract] [Full-text]
14. Review of the literature on benzene exposure and leukemia subtypes.
    Chem Biol Interact, 153: 9-21. [Abstract] [Full-text]
15. Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.
    Am J Hematol, 79(2): 132-5. [Abstract] [Full-text]
16. Ethnicity variables in the incidence rates of leukemias in New Zealand populations: implications for stem-cell transplantation.
    Am J Hematol, 79(2): 114-8. [Abstract] [Full-text]
17. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Am J Hematol, 79(2): 136-41. [Abstract] [Full-text]
18. Cell apoptosis induced by a synthetic carbazole compound LCY-2-CHO is mediated through activation of caspase and mitochondrial pathways.
    Biochem Pharmacol, 70(1): 102-12. [Abstract] [Full-text]
19. Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome.
    Genes Chromosomes Cancer, 43(4): 383-9. [Abstract] [Full-text]
20. An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase.
    Eur J Haematol, 75(1): 73-7. [Abstract] [Full-text]
21. Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.
    Eur J Haematol, 75(1): 41-6. [Abstract] [Full-text]
22. Acquired inv(9): what is its significance?
    Cancer Genet Cytogenet, 160(1): 76-8. [Abstract] [Full-text]
23. Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11.
    Cancer Genet Cytogenet, 160(1): 68-72. [Abstract] [Full-text]
24. Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.
    Oncogene, 24(22): 3678-83. [Abstract] [Full-text]
25. In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.
    Mol Cancer Ther, 4(6): 885-900. [Abstract] [Full-text]
26. Acute myeloid leukemia stem cells.
    Ann N Y Acad Sci, 1044: 1-5. [Abstract] [Full-text]
27. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
    J Clin Oncol, 23(18): 4179-91. [Abstract] [Full-text]
28. Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
    J Clin Oncol, 23(18): 4110-6. [Abstract] [Full-text]
29. Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometry.
    Cytometry A, 66(1): 71-7. [Abstract] [Full-text]
30. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia.
    Oncogene, 24(25): 4129-37. [Abstract] [Full-text]
31. Improved detection of minimal acute myeloid leukemia cells by the use of the combined parameters of XE-2100 hematology analyzer.
    Cytometry B Clin Cytom, 66(1): 18-24. [Abstract] [Full-text]
32. Molecular biomarkers for the study of childhood leukemia.
    Toxicol Appl Pharmacol, 206(2): 237-45. [Abstract] [Full-text]
33. Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.
    Blood, 106(1): 318-27. [Abstract] [Full-text]
34. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
    Blood, 106(1): 345-52. [Abstract] [Full-text]
35. AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.
    Blood, 106(1): 265-73. [Abstract] [Full-text]
36. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.
    Blood, 106(1): 27-34. [Abstract] [Full-text]
37. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
    J Lab Clin Med, 145(6): 295-304. [Abstract] [Full-text]
38. Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6.
    Leuk Res, 29(8): 893-9. [Abstract] [Full-text]
39. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature.
    Cancer, 104(1): 110-7. [Abstract] [Full-text]
40. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
    Cancer, 104(1): 101-9. [Abstract] [Full-text]
41. Identification of a novel HLA-DRB1 allele (HLA-DRB1*111902*).
    Tissue Antigens, 66(1): 67-8. [Abstract] [Full-text]
42. Lifestyle factors and the risk of adult leukemia in Canada.
    Cancer Causes Control, 16(5): 489-500. [Abstract] [Full-text]
43. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.
    FASEB J, 19(9): 1067-77. [Abstract] [Full-text]
44. Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts.
    BMC Cancer, 5(1): 60. [Abstract] [Full-text]
45. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.
    Pediatr Blood Cancer, 45(2): 212-6. [Abstract] [Full-text]
46. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.
    Mol Cell Biol, 25(14): 5869-79. [Abstract] [Full-text]
47. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
    Cancer Chemother Pharmacol, 56(3): 322-7. [Abstract] [Full-text]

© 2004-2012 Acute Myeloid Leukemia Research Today. All Rights Reserved.